Phoenixbio group

Phoenixbio Group: Revolutionizing Drug Development with PXB Mice

Phoenixbio Group is a leading provider of contract research services for drug development, utilizing the world's most widely used human liver chimeric mouse, the PXB mouse. With a focus on providing high-quality and reliable preclinical testing services to pharmaceutical and biotech companies worldwide, Phoenixbio Group has established itself as a trusted partner in the drug development industry.

The company was founded in 2000 by Dr. Tetsuya Ishii, who recognized the need for more accurate and predictive preclinical models for drug development. He developed the PXB mouse model by transplanting human hepatocytes into immunodeficient mice, resulting in a chimeric mouse with functional human liver cells. This breakthrough technology has since been widely adopted by researchers around the world as an essential tool for evaluating drug efficacy and toxicity.

Phoenixbio Group offers a range of contract research services using PXB mice, including pharmacokinetic studies, toxicology testing, efficacy evaluation, and disease modeling. The company's state-of-the-art facilities are equipped with advanced imaging systems and analytical instruments to provide comprehensive data analysis for clients.

One of Phoenixbio Group's key strengths is its team of experienced scientists who are dedicated to providing customized solutions tailored to each client's specific needs. The company works closely with clients throughout every stage of their projects to ensure that they receive timely updates on progress and results.

In addition to its contract research services, Phoenixbio Group also offers training programs for researchers interested in working with PXB mice. These programs provide hands-on experience in handling and working with these unique animal models under strict ethical guidelines.

Phoenixbio Group is committed to advancing scientific knowledge through innovation and collaboration. The company actively collaborates with academic institutions and other organizations around the world to develop new applications for its technology platform.

Overall, Phoenixbio Group is an innovative leader in preclinical research using humanized animal models. Its use of PXB mice has revolutionized drug development by providing more accurate and predictive models for evaluating drug efficacy and toxicity. With its commitment to quality, reliability, and customer satisfaction, Phoenixbio Group is poised to continue making significant contributions to the field of drug development for years to come.